5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine.
5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine. Diabetes Obes Metab. 2024 Feb; 26(2):463-472.